4//SEC Filing
Peng Katie 4
Accession 0000950170-24-100178
CIK 0001720580other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:07 PM ET
Size
8.0 KB
Accession
0000950170-24-100178
Insider Transaction Report
Form 4
Adicet Bio, Inc.ACET
Peng Katie
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-21+70,200→ 70,200 totalExercise: $3.38Exp: 2033-07-09→ Common Stock (70,200 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-08-21−70,200→ 0 totalExercise: $2.14Exp: 2033-07-09→ Common Stock (70,200 underlying)
Footnotes (2)
- [F1]Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
- [F2]The shares subject to this option shall vest in thirty-six (36) equal monthly installments commencing on July 10, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date.
Documents
Issuer
Adicet Bio, Inc.
CIK 0001720580
Entity typeother
Related Parties
1- filerCIK 0001983850
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 4:07 PM ET
- Size
- 8.0 KB